glp 1 agonist lizard The discovery of a digestion-slowing hormone in the Gila monster's venom paved the way for Ozempic. When a Gila monster named Pebbles needed medicine in return, a pharmaceutical chemist pivoted to help Gila monster inspires diabetes medicine

In the same area, BPC-157 may also provide some natural protection to the digestive system as a whole

It is possible that a sham or placebo surgery can deliver the same results

Refinement of current pharmacologic therapies: optimizing biologics and small-molecule agents Pharmacological treatment of IBD has entered a phase of diversification and personalization, primarily consisting of biologics and small-molecule therapies

Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor

Etiology of alcoholic cardiomyopathy: Mitochondria, oxidative stress and apoptosis

A COA that reports and limits it shows a careful process